Dr. Aziza Jamal-Allial leads several post-market requirement and post-authorization safety studies investigating drug safety during pregnancy and their impact on pregnancy outcomes and congenital malformations. In this capacity, she is involved in the development and execution of study protocols and facilitates communication with study sponsors and collaborators. Dr. Jamal-Allial leverages her vast data experience in algorithm development, data management, performing analysis, dissemination, and reporting of study results. She has experience in pregnancy and infant outcomes, drug safety, cancer, cardiovascular disease, diabetes, blood disorders, nutrition, and medical device.